121 related articles for article (PubMed ID: 8548588)
1. [Polyunsaturated fatty acids and their metabolites in chronic inflammatory bowel disease].
Cabré i Gelada E; Esteve i Comas M
Gastroenterol Hepatol; 1995 Dec; 18(10):515-25. PubMed ID: 8548588
[No Abstract] [Full Text] [Related]
2. Bowel rest or bowel starvation: defining the role of nutritional support in the treatment of inflammatory bowel diseases.
Culpepper-Morgan JA; Floch MH
Am J Gastroenterol; 1991 Mar; 86(3):269-71. PubMed ID: 1998306
[No Abstract] [Full Text] [Related]
3. Mechanisms of diarrhea in inflammatory bowel diseases.
Binder HJ
Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment.
Belluzzi A
Eur Rev Med Pharmacol Sci; 2004; 8(5):225-9. PubMed ID: 15638235
[TBL] [Abstract][Full Text] [Related]
5. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease.
Ueda Y; Kawakami Y; Kunii D; Okada H; Azuma M; Le DS; Yamamoto S
Nutr Res; 2008 Apr; 28(4):239-44. PubMed ID: 19083414
[TBL] [Abstract][Full Text] [Related]
6. Essential fatty acid depletion in children with inflammatory bowel disease.
Socha P; Ryzko J; Koletzko B; Celinska-Cedro D; Woynarowski M; Czubkowski P; Socha J
Scand J Gastroenterol; 2005 May; 40(5):573-7. PubMed ID: 16036510
[TBL] [Abstract][Full Text] [Related]
7. [Revision and consensus in nutritional therapy: nutrition in inflammatory intestinal diseases].
Fernández-Bañares F; Gassull Duro MA
Nutr Hosp; 1999 May; 14 Suppl 2():71S-80S. PubMed ID: 10548029
[TBL] [Abstract][Full Text] [Related]
8. [Role of mucins in inflammatory intestinal diseases].
Tytgat KM; Büller HA; Einerhand AW; van Deventer SJ; Dekker J
Ned Tijdschr Geneeskd; 1994 Nov; 138(48):2386-90. PubMed ID: 7990985
[No Abstract] [Full Text] [Related]
9. Inflammatory bowel disease: short- and long-term treatments.
Bickston SJ; Cominelli F
Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
[No Abstract] [Full Text] [Related]
10. Production of IL12p70 and IL23 by monocyte-derived dendritic cells in children with inflammatory bowel disease.
Damen GM; van Lierop P; de Ruiter L; Escher JC; Donders R; Samsom JN; Nieuwenhuis EE
Gut; 2008 Oct; 57(10):1480. PubMed ID: 18791123
[No Abstract] [Full Text] [Related]
11. [Study on the receptor proteins and transcription factors related to inflammatory bowel diseases].
Shu DZ; Zhou QX
Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):269-72. PubMed ID: 16270834
[No Abstract] [Full Text] [Related]
12. Diagnostics of inflammatory bowel disease.
Nikolaus S; Schreiber S
Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
[TBL] [Abstract][Full Text] [Related]
13. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
Stadnicki A; Mazurek U; Plewka D; Wilczok T
Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
[TBL] [Abstract][Full Text] [Related]
14. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.
Grimble RF; Tappia PS
Z Ernahrungswiss; 1998; 37 Suppl 1():57-65. PubMed ID: 9558730
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids and inflammatory bowel disease.
Belluzzi A; Boschi S; Brignola C; Munarini A; Cariani G; Miglio F
Am J Clin Nutr; 2000 Jan; 71(1 Suppl):339S-42S. PubMed ID: 10617993
[TBL] [Abstract][Full Text] [Related]
16. Essential fatty acids.
Lerman RH
Altern Ther Health Med; 2006; 12(3):20-9; quiz 30-1. PubMed ID: 16708767
[No Abstract] [Full Text] [Related]
17. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
[TBL] [Abstract][Full Text] [Related]
18. N-3 fatty acids for the treatment of inflammatory bowel diseases.
Belluzzi A
Proc Nutr Soc; 2002 Aug; 61(3):391-5. PubMed ID: 12296296
[TBL] [Abstract][Full Text] [Related]
19. Nutrition and inflammatory bowel disease.
Han PD; Burke A; Baldassano RN; Rombeau JL; Lichtenstein GR
Gastroenterol Clin North Am; 1999 Jun; 28(2):423-43, ix. PubMed ID: 10372275
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases].
Van Hees PA
Z Gastroenterol Verh; 1981 Jun; 19():7-14. PubMed ID: 6168136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
